Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

EU proceeds with action against Apple, Google

(Sharecast News) - The European Commission has decided to proceed with regulatory action against Apple and Google under its new digital competition rules.

Using the Digital Markets Act, the commission said it had taken a "preliminary view" that Google's search engine was prioritising results pointing to parent company Alphabet's own services over those of its rivals, breaching the requirement to treat third-party services in a "transparent, fair and non-discriminatory" way.

It added that said that Google Play, the company's app store, was stopping developers from giving consumers a "steer" on alternative offers that could be better.

The move is likely to increase tensions with US President Trump who has threatened tariffs against the 27-member bloc if moves were made to increase scrutiny of American technology firms.

Breaches of the Act can result in companies being fined 10% of revenue, or 20% if they reoffend. The commission told Apple it must make its operating systems available to devices made by competitors such as smartphones and wireless headphones, or else face the prospect of investigations and fines.

The order is designed to promote competition by making it possible for makers of rival technology to connect with Apple's devices, such as iPads and iPhones.

A second order was issued against Apple, demanding it provide a detailed timeline and methodology on how it will respond to requests from app developers to open up its systems.

"Companies operating in the EU, irrespective of their place of incorporation, must comply with EU rules, including the Digital Markets Act," said EU competition chief Teresa Ribera.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.